Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Cash flows from operating activities:
Net loss	$ (28,854,197)	$ (24,590,375)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	1,797,676	3,836,770
Change in fair value of warrants	(142,000)	(3,625,893)
Non-cash other financing costs		1,803,189
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	1,824,430	1,079,827
Accounts payable	284,542	1,013,138
Accrued expenses	(530,154)	(1,411,260)
Net cash used in operating activities	(25,619,703)	(21,894,604)
Cash flows from financing activities:
Proceeds from issuance of common stock, warrants, and pre-funded warrants, net	34,598,126	18,666,797
Proceeds from exercise of common stock options, net	1,999	0
Proceeds from exercise of warrants		8,025,003
Net cash provided by financing activities	34,600,125	26,691,800
Net increase in cash and cash equivalents	8,980,422	4,797,196
Cash and cash equivalents, beginning of period	10,551,916	5,754,720
Cash and cash equivalents, end of period	$ 19,532,338	10,551,916
Supplemental disclosure of cash flow information:
Reduction in value of warrants related to exercises		9,317,108
Cash paid for financing costs		$ 50,000